Evoke Pharma Inc (EVOK)
4.35
-0.15
(-3.33%)
USD |
NASDAQ |
Nov 22, 16:00
4.22
-0.13
(-2.99%)
After-Hours: 19:55
Evoke Pharma Total Assets (Quarterly): 14.15M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 14.15M |
| June 30, 2024 | 12.14M |
| March 31, 2024 | 12.45M |
| December 31, 2023 | 7.068M |
| September 30, 2023 | 7.853M |
| June 30, 2023 | 8.980M |
| March 31, 2023 | 10.04M |
| December 31, 2022 | 11.85M |
| September 30, 2022 | 13.41M |
| June 30, 2022 | 14.40M |
| March 31, 2022 | 9.026M |
| December 31, 2021 | 10.57M |
| September 30, 2021 | 11.65M |
| June 30, 2021 | 17.56M |
| March 31, 2021 | 19.30M |
| December 31, 2020 | 9.434M |
| September 30, 2020 | 6.751M |
| June 30, 2020 | 8.267M |
| March 31, 2020 | 4.638M |
| December 31, 2019 | 6.396M |
| September 30, 2019 | 7.327M |
| June 30, 2019 | 7.631M |
| March 31, 2019 | 4.363M |
| December 31, 2018 | 5.660M |
| Date | Value |
|---|---|
| September 30, 2018 | 7.018M |
| June 30, 2018 | 6.626M |
| March 31, 2018 | 5.585M |
| December 31, 2017 | 7.942M |
| September 30, 2017 | 10.76M |
| June 30, 2017 | 13.16M |
| March 31, 2017 | 14.84M |
| December 31, 2016 | 9.294M |
| September 30, 2016 | 10.81M |
| June 30, 2016 | 4.636M |
| March 31, 2016 | 6.872M |
| December 31, 2015 | 9.532M |
| September 30, 2015 | 11.68M |
| June 30, 2015 | 10.61M |
| March 31, 2015 | 12.62M |
| December 31, 2014 | 15.23M |
| September 30, 2014 | 13.39M |
| June 30, 2014 | 17.02M |
| March 31, 2014 | 22.57M |
| December 31, 2013 | 24.99M |
| September 30, 2013 | 23.74M |
| June 30, 2013 | |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.116M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.638M
Minimum
Mar 2020
19.30M
Maximum
Mar 2021
10.80M
Average
10.31M
Median
Total Assets (Quarterly) Benchmarks
| Repligen Corp | 2.831B |
| Eli Lilly and Co | 75.61B |
| MEI Pharma Inc | 27.75M |
| Revance Therapeutics Inc | 461.56M |
| NovaBay Pharmaceuticals Inc | 3.877M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.766M |
| Shareholders Equity (Quarterly) | 4.387M |
| Debt to Equity Ratio | 1.140 |
| Current Ratio | 1.437 |